Cargando…

799 Linezolid vs Vancomycin in the Treatment of Nosocomial Pneumonia: A Cost-effectiveness Analysis Incorporating Results from the ZEPHyR Trial

Detalles Bibliográficos
Autores principales:	Collins, Curtis, Schwemm, Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	IDWeek 2014 Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781444/ http://dx.doi.org/10.1093/ofid/ofu052.507

Ejemplares similares

1045 Linezolid Compared to Daptomycin for the Treatment of Vancomycin-resistant Enterococcal Urinary Tract Infections
por: Moenster, Ryan P., et al.
Publicado: (2014)

476 Heterogeneous Vancomycin-Intermediate Coagulase-Negative Staphylococci in Neonates: Does treatment with Linezolid improve outcomes?
por: Blanchard, Ana Chelène, et al.
Publicado: (2014)

1652 Retrospective Comparision of Oral Vancomycin Capsules vs Oral Vancomycin Solution for the Treatment of Severe Clostridium Defficile Infection
por: Saleh, Rania, et al.
Publicado: (2014)

339 An International, Multicenter, Retrospective Study of Nosocomial Pneumonia due to Pseudomonas aeruginosa
por: Micek, Scott, et al.
Publicado: (2014)

673 Comparative Effectiveness of Vancomycin vs Early Daptomycin for MRSA Bacteremia with Vancomycin MIC >1 mg/L: A Multicenter Evaluation
por: Moise, Pamela, et al.
Publicado: (2014)

312 Reduction of Nosocomial Blood Stream Infections (BSI) and Nosocomial Vancomycin-Resistant Enterococcus faecium (VRE) Colonisation on an Intensive Care Unit (ICU) after the Introduction of Antiseptic (Octenidine-based) Bathing: An Interrupted Time Series Analysis
por: Mattner, Frauke, et al.
Publicado: (2014)

678 Ceftaroline vs Vancomycin in Treatment for Skin and Soft Tissue Infections (SSTI) in Obese Patients
por: Nguyen, Hao, et al.
Publicado: (2014)

288 Lack of Synergy With Six Blood Isolates of Methicillin-Resistant Staphylococcus aureus (Vancomycin MIC of 2) Tested With Combinations of Vancomycin + Gentamicin, Vancomycin + Rifampin and Vancomycin + Cefazolin.
por: Long, Virginia, et al.
Publicado: (2014)

192 Vancomycin Dosing in Obese and Morbidly Obese Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia
por: Morrill, Haley, et al.
Publicado: (2014)

175 Cost-effectiveness of a Procalcitonin-Guided Treatment Algorithm in Sepsis
por: Collins, Curtis, et al.
Publicado: (2014)

1651 Role of Metronidazole vs Vancomycin as Initial Therapy in Hospitalized Patients with Mild to Moderate Clostridium difficile Infection (CDI) with NAP1 vs non-NAP1 Disease
por: Dubrovskaya, Yanina, et al.
Publicado: (2014)

266 Dalbavancin vs Vancomycin for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a subanalysis from the DISCOVER studies
por: Puttagunta, Sailaja, et al.
Publicado: (2014)

410 Tracking Linezolid Antimicrobial Activity and Resistance in North America: Results from LEADER 2013 Program
por: Flamm, Robert K., et al.
Publicado: (2014)

393 Vancomycin Dosing in Obese Patients
por: Alquwaizani, Mohammed, et al.
Publicado: (2014)

917 Nosocomial Respiratory Viral Infections in Two Children's Hospitals
por: Shah, Rita, et al.
Publicado: (2014)

396 What is the Best Predictor for Vancomycin Nephrotoxicity?
por: Hammoud, Kassem, et al.
Publicado: (2014)

728 Evaluation of Empirical Regimens Including Antistaphylococal Beta-lactam Antibiotics vs Vancomycin Monotherapy on Outcomes of Patients with Methicillin-Susceptible Staphylococcus aureus (MSSA) Bacteremia
por: Terico, Adrienne, et al.
Publicado: (2014)

341 Heterogeneous regional distribution of nosocomial infections due to ESBL-producing Enterobacteriaceae in Germany: Data from the German National Reference Center for the Surveillance of Nosocomial Infections (KISS)
por: Leistner, Rasmus, et al.
Publicado: (2014)

360 Surveillance for Carbapenemase-Producing Bacteria in the Wake of a Nosocomial Outbreak
por: Odom, Robin T., et al.
Publicado: (2014)

675 Outcomes of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) by vancomycin dosing regimen and vancomycin trough serum concentrations in the DISCOVER Program
por: Puttagunta, Sailaja, et al.
Publicado: (2014)

394 Influence of febrile neutropenia on the pharmacokinetics and dosage requirements of vancomycin
por: Shiotsuka, Shouichi, et al.
Publicado: (2014)

474 Ceftaroline Salvage Therapy for MRSA Bacteremia Following Vancomycin Failure
por: Pettit, Natasha, et al.
Publicado: (2014)

733 Vancomycin-Resistant Enterococcus (VRE) faecium Bloodstream Infections and Mortality
por: Suleyman, Geehan, et al.
Publicado: (2014)

688 The Effect of Preoperative Vancomycin on Bacteria Isolation from Operative Cultures
por: Young, Heather, et al.
Publicado: (2014)

1035 New Urine Reporting Criteria to Accurately Report Nosocomial Clinical Urinary Tract Infection
por: Schora, Donna, et al.
Publicado: (2014)

721 Decreasing Prevalence of Vancomycin-Heteroresistance (hVISA) among Methicillin-Resistant Staphylococcus aureus (MRSA) Blood Isolates over 10 years: Potential Impact of Vancomycin Treatment Guidelines
por: Khatib, Riad, et al.
Publicado: (2014)

392 Vancomycin Dosing and Concentrations at a Large University-Affiliated County Hospital
por: Youn, Gilmer, et al.
Publicado: (2014)

321 Screening Strategy to Detect Vancomycin-Resistant Enterococci Conversion in Exposed Roommates
por: Ng, Wil, et al.
Publicado: (2014)

409 Efficacy of Vancomycin against Biofilms of Neonatal Staphylococcus epidermidis Bloodstream Isolates
por: Simitsopoulou, Maria, et al.
Publicado: (2014)

775 Nosocomial Influenza (NI) in cancer patients during a high activity season in Mexico City
por: Vilar-Compte, Diana, et al.
Publicado: (2014)

985 Uncommon Outcomes due to Common Colds: Epidemiology and Outcomes Associated with Nosocomial Viral Infections in Children
por: Smathers, Sarah, et al.
Publicado: (2014)

976 Antiseptic tolerance and antimicrobial susceptibility of nosocomial Staphylococcus aureus at Texas Children's Hospital: 2007-2013
por: Mcneil, Jonathon, et al.
Publicado: (2014)

322 Vancomycin-resistant Enterococci with Reduced Daptomycin Susceptibility in Singapore: Prevalence and Associated Factor
por: Chow, Angela, et al.
Publicado: (2014)

862 Alcohol-Impregnated Disinfectant Caps Reduce The Rate Of Central-Line Associated Bloodstream Infections And Nosocomial Bacteremia
por: Shelly, Mark, et al.
Publicado: (2014)

337 Nosocomial Transmission of Carbapenem-Resistant Acinetobacter baumannii (CRAb) among ICU Patients Detected by CRAb-LAMP
por: Yamamoto, Norihisa, et al.
Publicado: (2014)

311 Reducing Nosocomial Infection in the NICU: A report on the first 10 years of our Performance Improvement Journey in Honolulu
por: Melish, Marian, et al.
Publicado: (2014)

1328 Decreased Vancomycin Use after Implementation of a Decision Support Program for Antibiotic Time Outs
por: Jones, Makoto, et al.
Publicado: (2014)

833 Lactobacillus GG (LGG) Does Not Eliminate Colonization by Vancomycin Resistant Enterococcus (VRE) in Adults with Comorbidities
por: Doron, Shira, et al.
Publicado: (2014)

236 Taking an Antibiotic Timeout: Utilizing an Antibiotic Renewal Template for Automatic Approval of Vancomycin and Piperacillin-tazobactam
por: Graber, Christopher J., et al.
Publicado: (2014)

271 Detection, evolution and outcome of the first case of Vancomycin Resistant Staphylococcus aureus (VRSA) infection in Europe
por: Melo-Cristino, Jose, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_kfm0ck1f4gvosnr7e5j4s8bg2d